Larsson O - Search Results

1

The Ras effectors NORE1A and RASSF1A are frequently inactivated in pheochromocytoma and abdominal paraganglioma.

Geli J, Kiss N, Lanner F, Foukakis T, Natalishvili N, Larsson O, Kogner P, Höög A, Clark GJ, Ekström TJ, Bäckdahl M, Farnebo F, Larsson C. Geli J, et al. Among authors: larsson c, larsson o. Endocr Relat Cancer. 2007 Mar;14(1):125-34. doi: 10.1677/ERC-06-0031. Endocr Relat Cancer. 2007. PMID: 17395981

2

Mevalonic acid is limiting for N-linked glycosylation and translocation of the insulin-like growth factor-1 receptor to the cell surface. Evidence for a new link between 3-hydroxy-3-methylglutaryl-coenzyme a reductase and cell growth.

Carlberg M, Dricu A, Blegen H, Wang M, Hjertman M, Zickert P, Höög A, Larsson O. Carlberg M, et al. Among authors: larsson o. J Biol Chem. 1996 Jul 19;271(29):17453-62. doi: 10.1074/jbc.271.29.17453. J Biol Chem. 1996. PMID: 8663239 Free article.

3

RIN14B: a pancreatic delta-cell line that maintains functional ATP-dependent K+ channels and capability to secrete insulin under conditions where it no longer secretes somatostatin.

Bränström R, Höög A, Wahl MA, Berggren PO, Larsson O. Bränström R, et al. Among authors: larsson o. FEBS Lett. 1997 Jul 14;411(2-3):301-7. doi: 10.1016/s0014-5793(97)00723-0. FEBS Lett. 1997. PMID: 9271225 Free article.

4

Expression of insulin-like growth factor-1 receptor in synovial sarcoma: association with an aggressive phenotype.

Xie Y, Skytting B, Nilsson G, Brodin B, Larsson O. Xie Y, et al. Among authors: larsson o. Cancer Res. 1999 Aug 1;59(15):3588-91. Cancer Res. 1999. PMID: 10446966

5

Co-existence of SYT-SSX1 and SYT-SSX2 fusions in synovial sarcomas.

Yang K, Lui WO, Xie Y, Zhang A, Skytting B, Mandahl N, Larsson C, Larsson O. Yang K, et al. Among authors: larsson c, larsson o. Oncogene. 2002 Jun 13;21(26):4181-90. doi: 10.1038/sj.onc.1205569. Oncogene. 2002. PMID: 12037676

6

Evaluation of immunohistochemical parameters as prognostic markers in malignant fibrous histiocytoma.

Ahlén J, Weng WW, Brosjö O, Von Rosen A, Larsson O, Larsson C. Ahlén J, et al. Among authors: larsson c, larsson o. Oncol Rep. 2003 Sep-Oct;10(5):1641-5. doi: 10.3892/or.10.5.1641. Oncol Rep. 2003. PMID: 12883752

7

Gain of 17q in malignant fibrous histiocytoma is associated with a longer disease-free survival and a low risk of developing distant metastasis.

Weng WH, Ahlén J, Lui WO, Brosjö O, Pang ST, Von Rosen A, Auer G, Larsson O, Larsson C. Weng WH, et al. Among authors: larsson c, larsson o. Br J Cancer. 2003 Aug 18;89(4):720-6. doi: 10.1038/sj.bjc.6601069. Br J Cancer. 2003. PMID: 12915885 Free PMC article.

8

Insulin-like growth factor type 1 receptor expression correlates to good prognosis in highly malignant soft tissue sarcoma.

Ahlén J, Wejde J, Brosjö O, von Rosen A, Weng WH, Girnita L, Larsson O, Larsson C. Ahlén J, et al. Among authors: larsson c, larsson o. Clin Cancer Res. 2005 Jan 1;11(1):206-16. Clin Cancer Res. 2005. PMID: 15671548

9

The insulin-like growth factor-1 receptor inhibitor PPP produces only very limited resistance in tumor cells exposed to long-term selection.

Vasilcanu D, Weng WH, Girnita A, Lui WO, Vasilcanu R, Axelson M, Larsson O, Larsson C, Girnita L. Vasilcanu D, et al. Among authors: larsson c, larsson o. Oncogene. 2006 May 25;25(22):3186-95. doi: 10.1038/sj.onc.1209339. Oncogene. 2006. PMID: 16407828

10

A 10-year-old girl with bifocal synovial sarcoma.

Weng WH, Claviez A, Krams M, Hashemi J, Larsson O, Larsson C, Suttorp M. Weng WH, et al. Among authors: larsson c, larsson o. Lancet Oncol. 2006 Jul;7(7):605-7. doi: 10.1016/S1470-2045(06)70762-8. Lancet Oncol. 2006. PMID: 16814213 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

544 results

Search Page

Filters